‹ All Posts
Mayank Kumar

15th Jul 2024 · SEBI-Registered Analyst

Lupin: The US FDA inspection at the Dabhasa manufacturing facility in Gujarat ended with no observations and received an Establishment Inspection Report with the 'No Action Indicated' classification. Alembic Pharmaceuticals: The pharmaceutical company received tentative US FDA approval for Selexipag injection. Sunteck Realty: The real estate company in its first quarter reported pre-sales at Rs 502 crore, up 30% year-on-year, and collection at Rs 342 crore, up 19% year-on-year. EMS: The company headquartered in Delhi received an LOA worth Rs 140 crore from Uttarakhand Power Corporation to supply installation services contracts for the execution of distribution infrastructure development. General Insurance Corporation of India: Radhika CS takes charge as Executive Director effective today. RVNL: The construction arm of the Ministry of Railways received a LoA from Central Railways for a Rs 133 crore project in Maharashtra. Apollo Micro Systems: The company received the Make II project from the Indian Army for the supply of a vehicle-mounted counter-swarm drone system. GTPL: The aerospace and defence company received the I&B Ministry's nod for providing headend-in-the -sky (HITS) services. Central Bank of India: The bank is in a co-lending partnership with Shriram Housing Finance to offer MSME loans and a co-lending partnership with Arka Fincap to offer MSME loans. Piramal Pharma: The US FDA pre-approval was inspected at the Ahmedabad facility and closed with zero observations.

#FundamentalViews#Post-ClosingCommentary#Miscellaneous#PsychologyofMoney
3 likes